Clinical Global Impression

Quetiapine Versus Haloperidol in the Treatment of Delirium: A Double-Blind, Randomized, Controlled Trial.

Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial.

Drug Des Devel Ther. 2013; 7: 657-67
Maneeton B, Maneeton N, Srisurapanont M, Chittawatanarat K

Atypical antipsychotic drugs may have low propensity to induce extrapyramidal side… Continue reading

Gang Membership, Violence, and Psychiatric Morbidity.

Gang Membership, Violence, and Psychiatric Morbidity.

Am J Psychiatry. 2013 Jul 12;
Coid JW, Ullrich S, Keers R, Bebbington P, Destavola BL, Kallis C, Yang M, Reiss D, Jenkins R, Donnelly P

OBJECTIVE Gang members engage in many high-risk… Continue reading

Neuropsychological Functioning in Late-Life Depression.

Neuropsychological functioning in late-life depression.

Front Psychol. 2013; 4: 381
Dybedal GS, Tanum L, Sundet K, Gaarden TL, Bjølseth TM

Background: The literature describing neurocognitive function in patients with late-life depression (LLD) show inconsistent findings in regard to incidence… Continue reading

Circulating Cortisol-Associated Signature of Glucocorticoid-Related Gene Expression in Subcutaneous Fat of Obese Subjects.

Circulating cortisol-associated signature of glucocorticoid-related gene expression in subcutaneous fat of obese subjects.

Obesity (Silver Spring). 2013 May; 21(5): 960-7
Pavlatou MG, Vickers KC, Varma S, Malek R, Sampson M, Remaley AT, Gold PW, Skarulis MC, Kino T

Serum… Continue reading

FACTORS IMPACTING DECISIONS to DECLINE or ADHERE to ANTIDEPRESSANT MEDICATION in PERINATAL WOMEN WITH MOOD and ANXIETY DISORDERS.

FACTORS IMPACTING DECISIONS TO DECLINE OR ADHERE TO ANTIDEPRESSANT MEDICATION IN PERINATAL WOMEN WITH MOOD AND ANXIETY DISORDERS.

Depress Anxiety. 2013 Jun 18;
Misri S, Eng AB, Abizadeh J, Blackwell E, Spidel A, Oberlander TF

PURPOSE: To identify specific… Continue reading

S-Adenosyl-L-Methionine Augmentation in Patients With Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study.

S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study.

ScientificWorldJournal. 2013; 2013: 204649
De Berardis D, Marini S, Serroni N, Rapini G, Iasevoli F, Valchera A, Signorelli M, Aguglia E,… Continue reading

Chronic Unpredictable Stress (CUS)-Induced Anxiety and Related Mood Disorders in a Zebrafish Model: Altered Brain Proteome Profile Implicates Mitochondrial Dysfunction.

Chronic Unpredictable Stress (CUS)-Induced Anxiety and Related Mood Disorders in a Zebrafish Model: Altered Brain Proteome Profile Implicates Mitochondrial Dysfunction.

PLoS One. 2013; 8(5): e63302
Chakravarty S, Reddy BR, Sudhakar SR, Saxena S, Das T, Meghah V, Brahmendra Swamy… Continue reading

Prospective, Open-Label Trial Measuring Satisfaction and Convenience of Two Formulations of Lamotrigine in Subjects With Mood Disorders.

Prospective, open-label trial measuring satisfaction and convenience of two formulations of lamotrigine in subjects with mood disorders.

Patient Prefer Adherence. 2013; 7: 411-417
Sajatovic M, Thompson TR, Nanry K, Edwards S, Manjunath R

Lamotrigine is an anticonvulsant drug indicated… Continue reading

QSAR Models for the Prediction of Plasma Protein Binding.

QSAR models for the prediction of plasma protein binding.

Bioimpacts. 2013; 3(1): 21-7
Ghafourian T, Amin Z

The prediction of plasma protein binding (ppb) is of paramount importance in the pharmacokinetics characterization of drugs, as it causes significant changes… Continue reading

Population Management of Diabetes in a High-Need Urban Community in the Bronx: The Experience of Montefiore Medical Center.

Population Management of Diabetes in a High-Need Urban Community in the Bronx: The Experience of Montefiore Medical Center.

Diabetes Educ. 2013 May 14;
Farrell P, Barnaby S, Galarza T, Simonson JK, Zonszein J, Meara A, Chung H, Figueira R,… Continue reading